Our Impact

Since we began in 2001, m2m has…

Created over 11,000 jobs for women living with HIV.

Reached more than 11M women and children under two in sub-Saharan Africa.

We undertake in-depth routine evaluations.

We also release regular quarterly reports with our latest reach and impact.

DOWNLOAD 2018 EVALUATION

DOWNLOAD LATEST QUARTERLY REPORT

In 2018, m2m…

Grew in scale

932,431

new clients were enrolled directly into our programme, a 4% increase from the year before.

> 1,750

women living with HIV were employed directly by m2m as Frontline Health Workers called “Mentor Mothers.”

498

locations in which Mentor Mothers provided direct services, including health facilities and in the surrounding communities – a 57% increase over 2018.

Took a step closer to an HIV-free generation

1.9%

is the mother-to-child HIV transmission rate among enrolled m2m clients—well below the 5% UN benchmark. This makes 2019 the sixth straight year we have achieved virtual elimination.

97%

of infants born to m2m clients living with HIV received antiretroviral medication, significantly up from 90% in 2018.

84%

of children born to m2m clients living with HIV received a final HIV test between 18-24 months, a significant increase from 75% in 2018. This highlights how m2m is keeping our clients in care through the breastfeeding period, when 47% of infections occur. [1]

1.^ UNICEF 2018: https://data.unicef.org/resources/women-at-the-heart-of-the-hiv-response-for-children/

Improved the health of women, children, and adolescents

Women

97%

of our clients who tested HIV-positive were enrolled on treatment, compared to a 93% benchmark in Eastern and Southern Africa. [2]

0.08%

of m2m’s HIV-negative pregnant or breastfeeding mothers acquired HIV in 2019, 45 times lower than a 2020 rate across sub-Saharan Africa of 3.6%. [3]

99%

of our clients living with HIV were adherent to their treatment more than 80% of the time, a critical threshold to achieving viral suppression.

94%

of our clients living with HIV who started antiretroviral therapy for the first time were alive and remained in treatment after a year, compared to a 75% retention rate in Eastern and Southern Africa at 12 months. [4]

2.^ UNAIDS 2018

3.^https://journals.lww.com/aidsonline/Abstract/2020/04010/Incident_HIV_among_pregnant_and_breast_feeding.12.aspx

4.^ UNAIDS 2018

Children

30,775

children and caregivers benefitted from our integrated Early Childhood Development (ECD) services across Eswatini, Kenya, Malawi, and South Africa in 2018.